The ELC Group has appointed Inna Demidova to head up its planned Moscow office as head of regulatory affairs for Russia and the Commonwealth of Independent States (CIS).
She moves to the Cambridge, UK-headquartered company from Ferring Pharmaceuticals, where she served as its regulatory affairs manager, and prior to that she worked at Wyeth (now part of Pfizer) and Lilly.
ELC Group's CEO Marco Rubenstein said: “We are very pleased to welcome Inna to the ELC Group team. Her knowledge and experience of the Russian and CIS territories is extremely impressive and we look forward to rapidly expanding our presence under her expert guidance.”
ELC plans to open its Moscow office later this year and is eyeing further expansion in Brazil and China soon.
No results were found
For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...